Search results
Results From The WOW.Com Content Network
Mankind Pharma is an Indian multinational pharmaceutical and healthcare product company, headquartered in Delhi. The company has products in therapeutic areas ranging from antibiotics, to gastrointestinal, cardiovascular, dermal, and erectile dysfunction medications. [5] [6] [7] As of 2023, Mankind Pharma had 25 factories and 6 R&D centres in ...
History [ edit ] Founded in February 1991, the company's present form is a result of a 2003 merger of three companies owned by Alfred E. Mann: Pharmaceutical Discovery Corporation (PDC), the cancer vaccine developer CTL ImmunoTherapies, Inc., and its sister company Allecure Corp, which was developing an allergy vaccine technology.
Pathkind Labs was set up in 2016. It is promoted by diagnostic industry veteran Sanjeev Vashishta and the promoters of Mankind Pharma. [4] Pathkind Diagnostics began its operations in August 2017 and currently operates in 20+ states in India. The company has a network of over 70 labs and more than 2000+ collection centers.
A key supply chain that feeds America’s pharmaceutical research apparatus remains snarled. And the future of a primate species mankind has relied upon for medical advancement hangs in the ...
Another of the Searle trust’s top beneficiaries is the State Policy Network, which has received nearly $9 million – in addition to other funds that went to individual organizations that ...
Ramesh C. Juneja (born 28 July 1955) is an Indian billionaire businessman and the Chairman of Mankind Pharma. [1] He is one of the 100 richest Indians as per Forbes ; [ 2 ] his net worth was estimated to be $2.3 billion in 2019.
For four seasons, Apple TV+'s For All Mankind has presented an alternate history of the space race, starting in a world where Russia, not America, put the first person on the moon.That single ...
Its R&D developed a drug to treat asthma and COPD and licensed this to North America and Japan. It also licensed out a new diabetes drug to the German Merck. [3] For the financial year 2016–2017 its sales were around 81 billion INR (ca. $1.25 billion), making it the fourth-biggest Indian pharmaceutical company. [12]